Patents by Inventor Sally A. Holick

Sally A. Holick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4521410
    Abstract: A compound which is biologically active in maintaining calcium and phosphorous metabolism in animals, selected from the group consisting of formula (IA) and (IB): ##STR1## wherein the bond between carbons C-22 and C-23 is single or double; Y is hydrogen, F, --CH.sub.3 or --CH.sub.2 CH.sub.3 ; Z is F, H or X; Y' is H, --CH.sub.3 or --CH.sub.2 CH.sub.3 ; Z' is F or H; Q.sup.a is CF.sub.3 or CH.sub.2 X; Q.sup.b is CF.sub.3 or CH.sub.3 ; X is selected from the group consisting of hydrogen and --OR.sup.1, wherein R.sup.1 is hydrogen or an orthoester glycoside radical of the formula (II) ##STR2## where A represents a glucofuranosyl or glucopyranosyl ring; R.sup.2 is hydrogen, lower alkyl, aralkyl, or aryl; and R.sup.3 is hydrogen or a straight or branched chain glycosidic residue containing 1-100 glycosidic units per residue; with the proviso that at least one of the R.sup.1 is an orthoester glycoside moiety of formula (II).
    Type: Grant
    Filed: May 3, 1984
    Date of Patent: June 4, 1985
    Assignee: The General Hospital Corporation
    Inventors: Michael F. Holick, Sally A. Holick
  • Patent number: 4457918
    Abstract: A water soluble vitamin compound of the formula selected from the group consisting of: ##STR1## wherein R.sup.1 is a straight or branched chain glycosidic residue containing 1-20 glycosidic units per residue, and R.sup.2 and R.sup.3 are hydrogen or R.sup.1, with the proviso that at least one of R.sup.2 or R.sup.3 is R.sup.1.
    Type: Grant
    Filed: May 12, 1982
    Date of Patent: July 3, 1984
    Assignee: The General Hospital Corporation
    Inventors: Michael F. Holick, Sally A. Holick
  • Patent number: 4410515
    Abstract: A synthetic compound which is biologically active in maintaining calcium and phosphorous metabolism in animals, of the formula I ##STR1## wherein the double bond between positions C-22 and C-23 is single or double; R.sup.2 is hydrogen, CH.sub.3 or CH.sub.2 CH.sub.3 ; X is selected from the group consisting of hydrogen and --OR.sup.1, where R.sup.1 is hydrogen or a straight or branched chain glycosidic residue containing 1-20 glycosidic units per residue; with the proviso that at least one of the R.sup.1 is a glycosidic residue.
    Type: Grant
    Filed: April 1, 1981
    Date of Patent: October 18, 1983
    Assignee: Massachusetts General Hospital
    Inventors: Sally A. Holick, Michael F. Holick